Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,245 | 5,328 | -6,816 | -30,371 | -23,984 |
| Depreciation Amortization | 209 | 150 | 87 | 487 | 387 |
| Accounts receivable | 583 | 800 | 1,000 | -1,000 | N/A |
| Accounts payable and accrued liabilities | -1,873 | 3,929 | 1,811 | -2,932 | 2,121 |
| Other Working Capital | -16,787 | -14,952 | 1,877 | -1,299 | 368 |
| Other Operating Activity | 3,295 | -3,600 | -1,961 | 5,988 | 538 |
| Operating Cash Flow | $-9,328 | $-8,345 | $-4,002 | $-29,127 | $-20,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 14 | 14 | N/A | -82 | -33 |
| Investing Cash Flow | $14 | $14 | $N/A | $-82 | $-33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,500 | 1,750 | N/A | 5,000 | 5,000 |
| Debt Repayment | -1,485 | N/A | -1,485 | -1,800 | -450 |
| Common Stock Issued | 3,794 | 2,060 | 2,059 | 12,612 | N/A |
| Other Financing Activity | -519 | -519 | -311 | -1,030 | -800 |
| Financing Cash Flow | $4,290 | $3,291 | $263 | $14,782 | $3,750 |
| Beginning Cash Position | 5,559 | 5,559 | 5,559 | 19,986 | 19,986 |
| End Cash Position | 535 | 519 | 1,820 | 5,559 | 3,133 |
| Net Cash Flow | $-5,024 | $-5,040 | $-3,739 | $-14,427 | $-16,853 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,328 | -8,345 | -4,002 | -29,127 | -20,570 |
| Capital Expenditure | N/A | N/A | N/A | -82 | -33 |
| Free Cash Flow | -9,328 | -8,345 | -4,002 | -29,209 | -20,603 |